Cargando…

650. Clinical Performance Evaluation of Virtuo Blood Culture System in a Tertiary Care Hospital

BACKGROUND: Bloodstream infections are a major cause of morbidity and mortality. BACT/ALERT VIRTUO (VIRTUO) blood culture system is an automated, closed system used with resin-containing media which may enhance the growth of microorganisms. Our objective was to assess the real-world performance of t...

Descripción completa

Detalles Bibliográficos
Autores principales: Chavez, Miguel A, Munigala, Satish, Burnham, Carey-Ann, Yarbrough, Melanie L, Warren, David K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777735/
http://dx.doi.org/10.1093/ofid/ofaa439.844
_version_ 1783630972207497216
author Chavez, Miguel A
Munigala, Satish
Burnham, Carey-Ann
Yarbrough, Melanie L
Warren, David K
author_facet Chavez, Miguel A
Munigala, Satish
Burnham, Carey-Ann
Yarbrough, Melanie L
Warren, David K
author_sort Chavez, Miguel A
collection PubMed
description BACKGROUND: Bloodstream infections are a major cause of morbidity and mortality. BACT/ALERT VIRTUO (VIRTUO) blood culture system is an automated, closed system used with resin-containing media which may enhance the growth of microorganisms. Our objective was to assess the real-world performance of the VIRTUO system. METHODS: We retrospectively reviewed all blood cultures performed between January-December 2018 (VersaTREK) and January-December 2019 (VIRTUO) at a 1250-bed academic medical center. Blood culture positivity rates, contamination rates, and time from collection to arrival in the laboratory were compared pre- versus post-VIRTUO implementation. Contamination was defined as a single blood culture with common skin microbiota. RESULTS: A total of 101803 blood cultures were performed during the study period: 48969 (48.1%) were processed with VersaTREK system and 52834 (51.9%) with VIRTUO system. A decreased median time from collection until arrival to the laboratory was seen post-implementation (2.0 pre- vs. 0.8 hours post-implementation, p< 0.001). The positivity rate increased from 3987 (8.1%) pre-implementation to 6141 (11.6%) post-implementation (p < 0.001) (Table and Figure). Staphylococcus aureus was the most frequently isolated species for both periods and had higher recovery rate with the VIRTUO system (717 (1.5%) pre- vs. 1764 (3.3%) post-implementation, p< 0.001). Higher recovery rate was also noted for other Staphylococcus spp. in the post-implementation period (985 (2.0%) pre- vs. 1644 (3.1%) post-implementation, p< 0.001). No difference in the organism recovery rate was noted for Streptococcus spp., Enterococcus faecium, E. faecalis, Pseudomonas aeruginosa, Enterobacterales, and Candida spp. The inpatient contamination rate was higher post-implementation (1.5% pre- vs. 1.9% post-implementation, p < 0.001). Comparison of blood culture positivity rate pre- vs. post-implementation, by culture location [Image: see text] Daily positivity rate for blood cultures processed at BJH during the study period [Image: see text] CONCLUSION: The VIRTUO system showed a higher rate of positive blood cultures compared to the VersaTREK system primarily from a higher detection of Staphylococcus spp. Further studies are needed to assess whether an increased rate of positive blood cultures is associated with changes in management and clinical outcomes. DISCLOSURES: All Authors: No reported disclosures
format Online
Article
Text
id pubmed-7777735
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-77777352021-01-07 650. Clinical Performance Evaluation of Virtuo Blood Culture System in a Tertiary Care Hospital Chavez, Miguel A Munigala, Satish Burnham, Carey-Ann Yarbrough, Melanie L Warren, David K Open Forum Infect Dis Poster Abstracts BACKGROUND: Bloodstream infections are a major cause of morbidity and mortality. BACT/ALERT VIRTUO (VIRTUO) blood culture system is an automated, closed system used with resin-containing media which may enhance the growth of microorganisms. Our objective was to assess the real-world performance of the VIRTUO system. METHODS: We retrospectively reviewed all blood cultures performed between January-December 2018 (VersaTREK) and January-December 2019 (VIRTUO) at a 1250-bed academic medical center. Blood culture positivity rates, contamination rates, and time from collection to arrival in the laboratory were compared pre- versus post-VIRTUO implementation. Contamination was defined as a single blood culture with common skin microbiota. RESULTS: A total of 101803 blood cultures were performed during the study period: 48969 (48.1%) were processed with VersaTREK system and 52834 (51.9%) with VIRTUO system. A decreased median time from collection until arrival to the laboratory was seen post-implementation (2.0 pre- vs. 0.8 hours post-implementation, p< 0.001). The positivity rate increased from 3987 (8.1%) pre-implementation to 6141 (11.6%) post-implementation (p < 0.001) (Table and Figure). Staphylococcus aureus was the most frequently isolated species for both periods and had higher recovery rate with the VIRTUO system (717 (1.5%) pre- vs. 1764 (3.3%) post-implementation, p< 0.001). Higher recovery rate was also noted for other Staphylococcus spp. in the post-implementation period (985 (2.0%) pre- vs. 1644 (3.1%) post-implementation, p< 0.001). No difference in the organism recovery rate was noted for Streptococcus spp., Enterococcus faecium, E. faecalis, Pseudomonas aeruginosa, Enterobacterales, and Candida spp. The inpatient contamination rate was higher post-implementation (1.5% pre- vs. 1.9% post-implementation, p < 0.001). Comparison of blood culture positivity rate pre- vs. post-implementation, by culture location [Image: see text] Daily positivity rate for blood cultures processed at BJH during the study period [Image: see text] CONCLUSION: The VIRTUO system showed a higher rate of positive blood cultures compared to the VersaTREK system primarily from a higher detection of Staphylococcus spp. Further studies are needed to assess whether an increased rate of positive blood cultures is associated with changes in management and clinical outcomes. DISCLOSURES: All Authors: No reported disclosures Oxford University Press 2020-12-31 /pmc/articles/PMC7777735/ http://dx.doi.org/10.1093/ofid/ofaa439.844 Text en © The Author 2020. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Poster Abstracts
Chavez, Miguel A
Munigala, Satish
Burnham, Carey-Ann
Yarbrough, Melanie L
Warren, David K
650. Clinical Performance Evaluation of Virtuo Blood Culture System in a Tertiary Care Hospital
title 650. Clinical Performance Evaluation of Virtuo Blood Culture System in a Tertiary Care Hospital
title_full 650. Clinical Performance Evaluation of Virtuo Blood Culture System in a Tertiary Care Hospital
title_fullStr 650. Clinical Performance Evaluation of Virtuo Blood Culture System in a Tertiary Care Hospital
title_full_unstemmed 650. Clinical Performance Evaluation of Virtuo Blood Culture System in a Tertiary Care Hospital
title_short 650. Clinical Performance Evaluation of Virtuo Blood Culture System in a Tertiary Care Hospital
title_sort 650. clinical performance evaluation of virtuo blood culture system in a tertiary care hospital
topic Poster Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777735/
http://dx.doi.org/10.1093/ofid/ofaa439.844
work_keys_str_mv AT chavezmiguela 650clinicalperformanceevaluationofvirtuobloodculturesysteminatertiarycarehospital
AT munigalasatish 650clinicalperformanceevaluationofvirtuobloodculturesysteminatertiarycarehospital
AT burnhamcareyann 650clinicalperformanceevaluationofvirtuobloodculturesysteminatertiarycarehospital
AT yarbroughmelaniel 650clinicalperformanceevaluationofvirtuobloodculturesysteminatertiarycarehospital
AT warrendavidk 650clinicalperformanceevaluationofvirtuobloodculturesysteminatertiarycarehospital